Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid sodium salt (commonly known as sodium hyaluronate) is the sodium salt form of hyaluronic acid, a naturally occurring glycosaminoglycan widely present in human connective, epithelial, and neural tissues. It acts as an effective tissue lubricant, wound healing promoter, and viscoelastic agent due to its ability to retain water and modulate cell signaling. It is used extensively in medicine for osteoarthritis (intra-articular injection), ophthalmology (maintenance of corneal shape and as an adjuvant in cataract/glaucoma surgery), dermatology (dermal fillers, wound healing, moisture retention in topicals), and as a component in various moisturizing and anti-aging products. The mechanism relates to its biophysical and biochemical roles as a lubricant, shock absorber, and modulator of inflammatory and cellular repair responses[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid sodium salt.